WHO & Regional Offices [to 26 Feb 2022]
https://www.who.int/
News [Selected]
25 February 2022
News release
Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season

24 February 2022
Statement
WHO Director-General: Deeply concerned over escalating health crisis in Ukraine

24 February 2022
Departmental news
WHO and NAM encourage digital platforms to apply global principles for identifying credible sources of health information
[See Perspectives above for detail]

23 February 2022
Departmental news
ILO-WHO step up collaboration to address health emergencies and promote healthier and safer working populations

23 February 2022
News release
Moving forward on goal to boost local pharmaceutical production, WHO establishes global biomanufacturing training hub in Republic of Korea

22 February 2022
Statement
Statement on Omicron sublineage BA.2
[See COVID above for detail]

22 February 2022
Departmental news
WHO launches new guideline for the control and elimination of human schistosomiasis

21 February 2022
Departmental news
The Vaccine Manufacturing Workshop for South-East Asia and Western Pacific Regions ended

21 February 2022
Joint News Release
New WHO/ILO guide urges greater safeguards to protect health workers

21 February 2022
Departmental news
WHO validates Saudi Arabia for eliminating trachoma as a public health problem

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region
:: New push to drive up Africa’s COVID-19 vaccination
24 February 2022 Brazzaville – One year since the COVAX Facility delivered the first COVID-19 vaccines to Africa, around 400 million doses have been administered – the region’s largest ever vaccine rollout in a single year. However, vaccination rates in the continent are the lowest in the world. To help bolster uptake, World Health Organization (WHO), UNICEF, Gavi, the Vaccine Alliance, and partners are supporting mass vaccination campaigns in 10 priority countries to reach 100 million people by the end of April 2022.
:: Mauritius’ strong COVID-19 vaccination drive reaches 76% of population 25 February 2022
:: Ramping up COVID-19 vaccination among Kenya’s hard-to-reach communities 22 February 2022

WHO Region of the Americas PAHO
:: PAHO Urges Increased Polio Vaccination of Children in the Americas
23 Feb 2022 Only 82% of children received a third dose of polio vaccine in 2020, the lowest rate since 1994 Washington, DC, February 23, 2022 (PAHO)- The Pan American Health Organization (PAHO) is calling on the countries of the Americas to redouble efforts to vaccinate children against polio.  The vaccination rate with all three doses of the polio…
:: Low vaccination rates in the Caribbean must be urgently addressed to stop the spread of COVID-19 says PAHO Director
23 Feb 2022 10 out of 13 countries and territories in the Americas yet to reach 40% coverage are in the Caribbean but the tide can still be turned with targeted interventions Washington D.C. 23 February 2022 (PAHO) – Low vaccination coverage in many countries of the Caribbean must be urgently addressed to stop the spread of COVID-19 and protect the most…

WHO South-East Asia Region SEARO
No new digest content identified

WHO European Region EURO
:: WHO/Europe Statement on Ukraine (24 February 2022) 24-02-2022

WHO Eastern Mediterranean Region EMRO
:: COVID-19 triggers critical care and ICU capacity-building by WHO in fragile, conflict-affected and vulnerable countries 24 February 2022
:: WHO and IsDB in Yemen: ensuring treatment for children with genetic blood disorders 23 February 2022
:: Somalia hosts first ever health research conference in Garowe 20 February 2022

WHO Western Pacific Region
No new digest content identified

 

::::::

WHO Events
https://www.who.int/news-room/events/2
[Selected]
9th ACT-Accelerator Facilitation Council meeting
28 February 2022 12:30 – 15:00 CET
Primary Objectives 
:: To take stock of progress to meet global COVID-19 targets for vaccines, tests, treatments and PPE
:: Share country experience, lessons learnt and progress in meeting global COVID-19 targets
:: Reinforce Facilitation Council commitment and political support for the ACT-Accelerator campaign

 

Expanding our understanding of post COVID-19 condition web series: Neurology and Mental Health
1 March 2022 13:30 – 15:30 CET

 

Global Evidence Review on Health and Migration: Strengthening information about health services related to NCDs for refugees and migrants to support evidence-based policy making on migration and health
1 March 2022 14:00 – 15:00 CET

 

Malaria vaccine R&D and immunization: lessons learned and considerations for global health impact
3 March 2022 09:00 – 12:00 ET

 

Immunization and vaccines related implementation research advisory committee (IVIR-AC) – March 2022
7 – 11 March 2022

 

::::::

New WHO Publications
https://www.who.int/publications/i
Selected Titles
25 February 2022
Shaping the global innovation and access landscape for better paediatric medicines
Overview
The lack of appropriate paediatric medicines and formulations is hindering the achievement of the Sustainable Development Goals and universal health coverage and is putting children’s lives at risk.
The Global Accelerator for Paediatric Formulations Strategy (GAP-f) 2022–2024 strategy builds from the work undertaken to date by the network of leading partners, both individually and collectively, through GAP-f. With this new strategy, we are excited to increase our footprint into a broader set of diseases to bring us closer to our vision of all children having equitable access to the medicines they need.

23 February 2022
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

23 February 2022
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

22 February 2022
WHO Pharmaceuticals Newsletter – N°1, 2022

21 February 2022
Global vaccine safety blueprint 2.0 (‎GVSB2.0)‎ 2021-2023
Overview
The lack of appropriate paediatric medicines and formulations is hindering the achievement of the Sustainable Development Goals and universal health coverage and is putting children’s lives at risk.
The Global Accelerator for Paediatric Formulations Strategy (GAP-f) 2022–2024 strategy builds from the work undertaken to date by the network of leading partners, both individually and collectively, through GAP-f. With this new strategy, we are excited to increase our footprint into a broader set of diseases to bring us closer to our vision of all children having equitable access to the medicines they need.